Reports - Oncology Market
HealthcareOncology Market
Oncology Market Valuation and Growth Forecast 2025-2035 by Cancer Diagnostics & Treatment (Cancer Diagnostics, Cancer Treatment) by Indication (Lungs Cancer, Colorectal Cancer, Breast Cancer, Liver Cancer, Bladder Cancer, Head & Neck Cancer, Prostate Cancer, Other Indications) by End Use (Hospitals, Diagnostic Laboratories, Diagnostic Imaging Centers, Academia, Specialty Clinics, Other End Uses) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Industry Leaders Trust Us For Actionable Intelligence
Table of Contents
Chapter 1 Executive Dashboard
1. Strategic Imperatives
Chapter 2 Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Chapter 3 Global Oncology Market - Segment Analysis
1. Overview
2. Global Oncology Market, 2021 - 2035 (USD Million)
3. Global Oncology Market - by Cancer Diagnostics & Treatment
3.1. By Cancer Diagnostics
3.2. By Cancer Treatment
4. Global Oncology Market - by Indication
4.1. By Lungs Cancer
4.2. By Colorectal Cancer
4.3. By Breast Cancer
4.4. By Liver Cancer
4.5. By Bladder Cancer
4.6. By Head & Neck Cancer
4.7. By Prostate Cancer
4.8. By Other Indications
5. Global Oncology Market - by End Use
5.1. By Hospitals
5.2. By Diagnostic Laboratories
5.3. By Diagnostic Imaging Centers
5.4. By Academia
5.5. By Specialty Clinics
5.6. By Other End Uses
6. Global Oncology Market - by region
6.1. North America
6.2. Europe
6.3. Asia Pacific
6.4. Latin America
6.5. Middle East & Africa
7. Market comparative analysis
Chapter 4 North America Oncology Market - Segment Analysis
1. Overview
2. North America Oncology Market, 2021 - 2035 (USD Million)
3. North America Oncology Market - by Cancer Diagnostics & Treatment
3.1. By Cancer Diagnostics
3.2. By Cancer Treatment
4. North America Oncology Market - by Indication
4.1. By Lungs Cancer
4.2. By Colorectal Cancer
4.3. By Breast Cancer
4.4. By Liver Cancer
4.5. By Bladder Cancer
4.6. By Head & Neck Cancer
4.7. By Prostate Cancer
4.8. By Other Indications
5. North America Oncology Market - by End Use
5.1. By Hospitals
5.2. By Diagnostic Laboratories
5.3. By Diagnostic Imaging Centers
5.4. By Academia
5.5. By Specialty Clinics
5.6. By Other End Uses
Chapter 5 Europe Oncology Market - Segment Analysis
1. Overview
2. Europe Oncology Market, 2021 - 2035 (USD Million)
3. Europe Oncology Market - by Cancer Diagnostics & Treatment
3.1. By Cancer Diagnostics
3.2. By Cancer Treatment
4. Europe Oncology Market - by Indication
4.1. By Lungs Cancer
4.2. By Colorectal Cancer
4.3. By Breast Cancer
4.4. By Liver Cancer
4.5. By Bladder Cancer
4.6. By Head & Neck Cancer
4.7. By Prostate Cancer
4.8. By Other Indications
5. Europe Oncology Market - by End Use
5.1. By Hospitals
5.2. By Diagnostic Laboratories
5.3. By Diagnostic Imaging Centers
5.4. By Academia
5.5. By Specialty Clinics
5.6. By Other End Uses
Chapter 6 Asia Pacific Oncology Market - Segment Analysis
1. Overview
2. Asia Pacific Oncology Market, 2021 - 2035 (USD Million)
3. Asia Pacific Oncology Market - by Cancer Diagnostics & Treatment
3.1. By Cancer Diagnostics
3.2. By Cancer Treatment
4. Asia Pacific Oncology Market - by Indication
4.1. By Lungs Cancer
4.2. By Colorectal Cancer
4.3. By Breast Cancer
4.4. By Liver Cancer
4.5. By Bladder Cancer
4.6. By Head & Neck Cancer
4.7. By Prostate Cancer
4.8. By Other Indications
5. Asia Pacific Oncology Market - by End Use
5.1. By Hospitals
5.2. By Diagnostic Laboratories
5.3. By Diagnostic Imaging Centers
5.4. By Academia
5.5. By Specialty Clinics
5.6. By Other End Uses
Chapter 7 Latin America Oncology Market - Segment Analysis
1. Overview
2. Latin America Oncology Market, 2021 - 2035 (USD Million)
3. Latin America Oncology Market - by Cancer Diagnostics & Treatment
3.1. By Cancer Diagnostics
3.2. By Cancer Treatment
4. Latin America Oncology Market - by Indication
4.1. By Lungs Cancer
4.2. By Colorectal Cancer
4.3. By Breast Cancer
4.4. By Liver Cancer
4.5. By Bladder Cancer
4.6. By Head & Neck Cancer
4.7. By Prostate Cancer
4.8. By Other Indications
5. Latin America Oncology Market - by End Use
5.1. By Hospitals
5.2. By Diagnostic Laboratories
5.3. By Diagnostic Imaging Centers
5.4. By Academia
5.5. By Specialty Clinics
5.6. By Other End Uses
Chapter 8 Middle East & Africa Oncology Market - Segment Analysis
1. Overview
2. Middle East & Africa Oncology Market, 2021 - 2035 (USD Million)
3. Middle East & Africa Oncology Market - by Cancer Diagnostics & Treatment
3.1. By Cancer Diagnostics
3.2. By Cancer Treatment
4. Middle East & Africa Oncology Market - by Indication
4.1. By Lungs Cancer
4.2. By Colorectal Cancer
4.3. By Breast Cancer
4.4. By Liver Cancer
4.5. By Bladder Cancer
4.6. By Head & Neck Cancer
4.7. By Prostate Cancer
4.8. By Other Indications
5. Middle East & Africa Oncology Market - by End Use
5.1. By Hospitals
5.2. By Diagnostic Laboratories
5.3. By Diagnostic Imaging Centers
5.4. By Academia
5.5. By Specialty Clinics
5.6. By Other End Uses
Chapter 9 Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
Chapter 10 COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Chapter 11 Marketing Strategy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Chapter 12 Competitive Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Chapter 13 Company Profiles
1. Ability Pharma
2. Thermo Fisher Scientific Inc.
3. Abbvie Inc.
4. Takeda Pharmaceutical Co. Ltd.
5. Astrazeneca Plc.
6. Pfizer Inc.
7. Sysmex Corporation
8. Bayer Ag
9. Agilent Technologies Inc.
10. Biogenex
Chapter 14 Key Primary Respondents - VERBATIM
Chapter 15 Discussion Guide
Chapter 16 Customization Offered
Chapter 17 Annexure
Chapter 18 List of Figures
Chapter 19 List of Tables
Chapter 20 List of Abbreviations
FAQ‘s
Related Reports
Contact
Toll Free Number+1 (877) 462-2282
© 2025 Vantage Market Research. All right reserved
Secured By